COVID-19 Impact and SARS-CoV-2 Viral Lifecycle

Funding Agency:
Pfizer Inc.

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.

The intent of this RFP is to support innovative and engaging online educational initiatives that increase awareness and understanding of the short and potential longer term impact of COVID-19, key steps in the SARSCoV-2 lifecycle, underlying medical conditions that increase risk of severe illness from COVID-19 and need for/therapeutic implications.

Projects that will be considered for Pfizer support will focus on:

• COVID-19 impact in United States: o Disease course and management o Hospitalizations and deaths o Indirect impact – psychological and mental health, delays to elective or non-urgent procedures, people not accessing health services, delays to diagnostic procedures (ref.)

• Key steps in the SARS-CoV-2 lifecycle: o Entry/fusion o Endosome maturation o Polypeptide chain cleavage by proteases o RNA replication

• Detection of SARS-CoV-2 infection relative to symptom onset over time 

• Understanding of comorbidities risk and the importance of early disease management

• Post-COVID-19 Conditions 

Proposals for independent medical education programs may include all activity formats, including live virtual, enduring virtual, innovative communication channels, apps, social media, digital programs, and resources or tools for clinical practice. Priority will be given to innovative CME programs structured to adapt to virtual learning.

Grant Application due date: July 15, 2021 (was July 8)

Agency Website

Eligibility Requirements

Geographic Scope United States

• The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations. All institutions must have a relevant role and the requesting organization must have a key role in the project. • For projects offering continuing education credit, the requesting organization must be accredited.

Amount Description

• Individual projects requesting up to $200,000 will be considered. The estimated total available budget related to this RFP is $1,000,000.

Funding Type





Curriculum Development
Medical - Clinical Science

External Deadline

July 15, 2021